Zeiss Vision Care has acquired a “comprehensive intellectual property (IP) portfolio, including a suite of patents,” from Mitsui Chemicals (MCI), a Japanese company with wide-ranging business lines, among them “vision care materials,” and an R&D department split between synthesis, polymer science and tech for manufacturing processes. Zeiss has not disclosed ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.